Drugs Safety Labeling Updates
Drugs Safety Labeling Updates
| Scientific Name | Trade Name | Updated Section | Safety-Related Labeling Changes | Month |
|---|---|---|---|---|
| Hydrochlorothiazide, Bisoprolol | Concor Plus | 4.4 Special Warnings and Special Precautions for Use 4.8 Undesirable effects | Acute respiratory distress syndrome (ARDS) | Sep,2022 |
| Hydrochlorothiazide, Amiloride | Amuretic | 4.4 Special Warnings and Special Precautions for Use 4.8 Undesirable effects | Acute respiratory distress syndrome (ARDS) | Sep,2022 |
| Hydrochlorothiazide | Monozide | 4.4 Special Warnings and Special Precautions for Use 4.8 Undesirable effectsa | Acute respiratory distress syndrome (ARDS) | Sep,2022 |
| Hydrochlorothiazide, Irbesartan | Coaprovel | 4.4 Special Warnings and Special Precautions for Use 4.8 Undesirable effects | Acute respiratory distress syndrome (ARDS) | Sep,2022 |
| Hydrochlorothiazide,Olmesartan | Olmetec Plus | 4.4 Special Warnings and Special Precautions for Use 4.8 Undesirable effects | Acute respiratory distress syndrome (ARDS) | Sep,2022 |
| Baricitinib | Olumiant | 4.4 Special Warnings and Special Precautions for Use | Serious heart-related problems, thrombosis, malignancies, mortality | Sep,2022 |